"ISTH guidelines for antithrombotic treatment in COVID-19": Comment from Huisman et al.

Huisman, Menno V; Klok, Frederikus A; Kamphuisen, Pieter W

Huisman, Menno V; Klok, Frederikus A; Kamphuisen, Pieter W.

Huisman MV; Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Klok FA; Department of Medicine MD PhD FESC - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
Kamphuisen PW; Department of Medicine, Tergooi MC Hilversum, and Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

J Thromb Haemost ; 20(11): 2708-2709, 2022 Nov.

Article in English | MEDLINE | ID: covidwho-2088283

Subject(s)

COVID-19 Drug Treatment; Humans; Fibrinolytic Agents/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Jth.15855

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google